.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Farmers Insurance
Healthtrust
Julphar
Mallinckrodt
Novartis
Federal Trade Commission
Colorcon
US Army
McKinsey

Generated: February 24, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Sweden Patent: 9804211

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo➤ Try a Free Trial➤ Try a Free TrialYYYTREATMENT OF POST-MYOCARDIAL INFARCTION
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo➤ Try a Free Trial➤ Try a Free TrialYYYTREATMENT OF STROKE
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo➤ Try a Free Trial➤ Try a Free TrialYYYREDUCTION OF THE RATE OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo➤ Try a Free Trial➤ Try a Free TrialYYYREDUCTION OF THE RATE OF CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION, AND STROKE IN PATIENTS WITH ACUTE CORONARY SYNDROME OR A HISTORY OF MYOCARDIAL INFARCTION
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-001Jul 20, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYYREDUCTION OF THE RATE OF CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION, AND STROKE IN PATIENTS WITH ACUTE CORONARY SYNDROME OR A HISTORY OF MYOCARDIAL INFARCTION
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-001Jul 20, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYYREDUCTION OF THE RATE OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-001Jul 20, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYYTREATMENT OF POST-MYOCARDIAL INFARCTION
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-001Jul 20, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialYYYTREATMENT OF STROKE
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo➤ Try a Free Trial➤ Try a Free TrialYYREDUCTION OF THE RATE OF CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION, AND STROKE IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo➤ Try a Free Trial➤ Try a Free TrialYYTREATMENT OF STROKE IN PATIENTS WITH ACUTE CORONARY SYNDROME OR A HISTORY OF MYOCARDIAL INFARCTION
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist